Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liu He

Showing results (421-430 of 442) with videos related to

Pageof 45
Sort By:
Pacing and Clinical Electrophysiology : PACE|March 13, 2025
Burden of Atrial Fibrillation and Atrial Flutter From 1990 to 2021 in China: Global Burden of Disease Study 2021 UpdateXiangyi Kong, Mingxiao Li, Liu He, et al.
Heart Rhythm|August 21, 2024
Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failureZixu Zhao, Yiping Wang, Chao Jiang, et al.
Heart Rhythm|November 2, 2025
Catheter ablation is associated with reduced cardiovascular events in atrial fibrillation patients with atrial functional mitral regurgitationQifan Li, Xiaodong Peng, Yiwei Lai, et al.
JMIR Research Protocols|February 18, 2026
Impact of the Population Medicine Multimorbidity Intervention in Xishui County (POPMIX) on People at High Risk for Chronic Obstructive Pulmonary Disease: Protocol for the POPMIX-COPD Cluster Randomized Controlled TrialChen Wang, Yuhao Liu, Ke Huang, et al.
American Heart Journal|August 25, 2024
Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trialChao Jiang, Zhiyan Wang, Xin Du, et al.
BMJ Open|May 6, 2026
Impact of the POPulation Medicine Multimorbidity Intervention in Xishui County (POPMIX) on people at high risk for COPD who smoke: protocol for the POPMIX-Smoking cluster randomised controlled trialSimiao Chen, Ke Huang, Zhoutao Zheng, et al.
JACC. Clinical Electrophysiology|June 12, 2026
Validation of Smartwatches Integrated With Photoplethysmography for Continuous Evaluation of Atrial Fibrillation BurdenSong Zuo, Le Zhou, Han Feng, et al.
Circulation|November 9, 2025
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical TrialChao Jiang, Zixu Zhao, Zejun Yang, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 8, 2020
The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry studyWang-Yang Yang, Xin Du, Chao Jiang, et al.
BMJ Open|December 21, 2025
Association of cognitive impairment with adverse cardiovascular outcomes: the mediating role of modifiable risk factors in a prospective cohort studyLe Zhou, Zejun Yang, Lan Ren, et al.
Pageof 45

Showing results (421-430 of 442) with videos related to

Sort By:
Pageof 45
Pacing and Clinical Electrophysiology : PACE|March 13, 2025
Burden of Atrial Fibrillation and Atrial Flutter From 1990 to 2021 in China: Global Burden of Disease Study 2021 UpdateXiangyi Kong, Mingxiao Li, Liu He, et al.
Heart Rhythm|August 21, 2024
Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failureZixu Zhao, Yiping Wang, Chao Jiang, et al.
Heart Rhythm|November 2, 2025
Catheter ablation is associated with reduced cardiovascular events in atrial fibrillation patients with atrial functional mitral regurgitationQifan Li, Xiaodong Peng, Yiwei Lai, et al.
JMIR Research Protocols|February 18, 2026
Impact of the Population Medicine Multimorbidity Intervention in Xishui County (POPMIX) on People at High Risk for Chronic Obstructive Pulmonary Disease: Protocol for the POPMIX-COPD Cluster Randomized Controlled TrialChen Wang, Yuhao Liu, Ke Huang, et al.
American Heart Journal|August 25, 2024
Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trialChao Jiang, Zhiyan Wang, Xin Du, et al.
BMJ Open|May 6, 2026
Impact of the POPulation Medicine Multimorbidity Intervention in Xishui County (POPMIX) on people at high risk for COPD who smoke: protocol for the POPMIX-Smoking cluster randomised controlled trialSimiao Chen, Ke Huang, Zhoutao Zheng, et al.
JACC. Clinical Electrophysiology|June 12, 2026
Validation of Smartwatches Integrated With Photoplethysmography for Continuous Evaluation of Atrial Fibrillation BurdenSong Zuo, Le Zhou, Han Feng, et al.
Circulation|November 9, 2025
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical TrialChao Jiang, Zixu Zhao, Zejun Yang, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 8, 2020
The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry studyWang-Yang Yang, Xin Du, Chao Jiang, et al.
BMJ Open|December 21, 2025
Association of cognitive impairment with adverse cardiovascular outcomes: the mediating role of modifiable risk factors in a prospective cohort studyLe Zhou, Zejun Yang, Lan Ren, et al.
Pageof 45